Study of Tumor Suppressor Proteins in Ocular Cancer
Author Information
Author(s): Vieira V., de la Houssaye G., Lacassagne E., Dufier J.L., Jaïs J.P., Beermann F., Menasche M., Abitbol M.
Primary Institution: Université Paris-Descartes, CERTO, Centre de Recherches Thérapeutiques en Ophtalmologie de la Faculté de Médecine Paris-Descartes-site Necker, AP-HP, Paris, France
Hypothesis
The study evaluates the roles of Dlg1, Scrib, and Lgl1 in tumorigenesis of ocular adenocarcinomas in a transgenic mouse model.
Conclusion
The study demonstrates that mislocalization and downregulation of Dlg1, Scrib, and Lgl1 are involved in ocular carcinogenesis.
Supporting Evidence
- Dlg1, Scrib, and Lgl1 are widely distributed in normal ocular tissues, particularly in retinal neurons.
- The three proteins are mislocalized in retinal layers during ocular carcinogenesis.
- Mislocalization of these proteins correlates with early dysplastic stages of ocular tumorigenesis.
- Downregulation of these proteins may serve as late-stage markers of the disease.
- Decreased levels of Dlg1, Scrib, and Lgl1 are associated with invasive stages of cancer.
Takeaway
The proteins Dlg1, Scrib, and Lgl1 help keep cells organized, and when they don't work right, it can lead to eye cancer in mice.
Methodology
The study used in situ hybridization, immunohistochemistry, RT-PCR, and western blot analysis to assess protein expression and localization.
Participant Demographics
Transgenic TRP1/Tag mice and control CB6 mice.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website